Rare Tumours in Children and Adolescents (STEP) (STEP 2 0)

University Hospital Tuebingen

Status: Enrolling

Conditions: Rare Diseases

Treatments: Other: Data collection

Study type: Observational

Funder types: Other

Identifiers

NCT05773651

STEP 2.0

Details and patient eligibility

About

The aim of the STEP registry is to collect and evaluate experience and data on the diagnosis and treatment of rare childhood tumors in order to use the knowledge gained to improve the treatment prospects for our patients. The rarity of a disease should not be a disadvantage for the young patients.

Full description

The objective of the STEP registry is to optimise the diagnosis and treatment of patients with rare tumour diseases in childhood and adolescence. Therefore, a continuous prospective collection of clinical data on rare paediatric tumours is conducted to improve the understanding of these tumours. Beyond analysis of clinical data, further scientific research on the biological and molecular genetic characteristics of these tumours is performed. These data and a close collaboration with international partners, especially the European EXPeRT group, enable the improvement of treatment recommendations for these tumours along with establishment a global interdisciplinary network of rare tumour specialists.

Enrollment: 10,000 estimated patients

Sex: All

Ages: 1 day to 18 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of a rare solid tumor
• Age at diagnosis: Neonatal period to 18 years (In the case of young adults, registration in the database and/or referral to advisory contact persons within the framework of the competence network can take place upon request and after declaration of consent.)
• Information, education, written consent of the patient or the guardian
• Not recorded in any of the existing clinical studies/ registers of the German Society for Pediatric Oncology and Hematology (GPOH)

Exclusion criteria

• Registration of the tumor diagnosis in a prospective therapy study/ another clinical registry of the GPOH
• Lack of information, explanation and/or written consent of the patient or the legal guardian.

Trial design

10,000 participants in 1 patient group

Rare tumor disease

Description:

Prospective epidemiological and clinical data collection of subjects with diagnosis of a rare solid tumor.

Treatment:

Other: Data collection